|
Report Date : |
08.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
MEDIPHAR LABORATORIES SARL |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
19.07.1973 |
|
|
|
|
Com. Reg. No.: |
4346, Baabda |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceutical preparations and vitamins |
|
|
|
|
No. of Employees : |
50 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
C1 |
C1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : MEDIPHAR LABORATORIES SARL
Country of Origin : Lebanon
Legal Form : Limited Liability Company
Registration Date : 19th July 1973
Commercial Registration Number : 4346, Baabda
Issued Capital : LP 700,000,000
Paid up Capital : LP 700,000,000
Total Workforce : 50
Activities : Manufacturers of pharmaceutical preparations and vitamins
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
MEDIPHAR
LABORATORIES SARL
Registered &
Physical Address
Building : Mediphar Building
Street : Main Road
Area : Zouk Khrab
PO Box : 60202
Town : Dbayeh
Country : Lebanon
Telephone : (961-4) 540715 / 540717
Facsimile : (961-4) 542821
Email : mediphar@medipharlabs.com
Premises
Subject operates
from a medium sized suite of offices and a factory that are owned and located
in the Central Business Area of Dbayeh.
Name Position
·
Nadia
Fadel Managing
Director
·
Fouad H
Fadel Director
·
Dr
Edmond H Fadel Director
·
Nathalie
H Fadel Director
Date of Establishment : 19th
July 1973
Legal Form :
Limited Liability Company
Commercial Reg. No. : 4346, Baabda
Issued Capital : LP 700,000,000
Paid up Capital : LP 700,000,000
Name of Shareholder
(s)
·
Nadia
Fadel
·
Fouad H
Fadel
·
Dr
Edmond H Fadel
·
Nathalie
H Fadel
Activities: Engaged in the manufacture of
pharmaceutical preparations and vitamins.
Import
Countries: France, Italy,
Switzerland and the United States of America.
Export
Countries: Romania, Jordan,
Iraq, Yemen, Kuwait and Ethiopia.
Brand Names: ACTI-VIR, ALZEPIL,
AMINOPHYLLINE, ANXYL, BEBECAL, BENZHEXOL, BIPAX, CINARIN,
CLINIDERM, COLDIN, DELINE, DERMICIN, DICLORETARD, DOXEPIN, ECOZONE,
FINACOR,
FLUOCINOLONE, FUROXYL, GLIBENCLAMIDE, HALOPERIDOL, KENATAR, LACTAPLUS,
LESSFAT, LEVOMED, MED-FOLIC ACID, MEDISTAN, NAUZEX, OFLOMED, OSTEOMED,
PARAMOL, PIROXICAM, PREDNISONE, RANIMED, RINEX, SERTINE, SPASMINE,
SULFANILAMIDE, TALUSIN, TERAFAN, TRETINOIN, TUSSIN, VASCOR and VITEX
Operating Trend: Steady
Subject has a
workforce of 50 employees.
Financial highlights
provided by local sources are given below:
Currency: Lebanese
Pounds (LP)
Year
Ending 31/12/10: Year
Ending 31/12/11:
Total Sales LP 11,000,000 LP 11,250,000,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Banque
Audi Sal
Ashrafieh Branch
PO Box: 112560
Tel: (961-1) 200250 / 200251
Fax: (961-1) 200955
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.15 |
|
UK Pound |
1 |
Rs.85.22 |
|
Euro |
1 |
Rs.69.24 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.